T F Busby - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

T F Busby

Showing results (11-20 of 17) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 17 results.

Vox Sanguinis|January 1, 1987

Heat stability of lyophilized C1 inactivator concentratesM Wickerhauser, C Williams, B L Kolen, et al.

The American Review of Respiratory Disease|July 1, 1983

Thermal denaturation of alpha 1-protease inhibitor. Stabilization by neutral salts and sugarsC B Glaser, T F Busby, K C Ingham, et al.

Molecular Immunology|January 1, 1992

Dynamic equilibria between subcomponents of C1, the first component of human complementK C Ingham, D J Milasincic, T F Busby, et al.

Biochemistry|November 23, 1993

Binding of heparin by type III domains and peptides from the carboxy terminal hep-2 region of fibronectinK C Ingham, S A Brew, M M Migliorini, et al.

Vox Sanguinis|January 1, 1985

Biological and physical properties of fibronectin pasteurized in the presence of stabilizersS I Miekka, T F Busby, L Tarshis, et al.

Haemophilia : the Official Journal of the World Federation of Hemophilia|January 5, 1999

New methods for inactivation of lipid-enveloped and non-enveloped virusesS I Miekka, T F Busby, B Reid, et al.

The Journal of Biological Chemistry|August 4, 1995

Heparin binding by fibronectin module III-13 involves six discontinuous basic residues brought together to form a cationic cradleT F Busby, W S Argraves, S A Brew, et al.

Pageof 2

Search research articles

Showing results (11-20 of 17) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 17 results.

Vox Sanguinis|January 1, 1987

Heat stability of lyophilized C1 inactivator concentratesM Wickerhauser, C Williams, B L Kolen, et al.

The American Review of Respiratory Disease|July 1, 1983

Thermal denaturation of alpha 1-protease inhibitor. Stabilization by neutral salts and sugarsC B Glaser, T F Busby, K C Ingham, et al.

Molecular Immunology|January 1, 1992

Dynamic equilibria between subcomponents of C1, the first component of human complementK C Ingham, D J Milasincic, T F Busby, et al.

Biochemistry|November 23, 1993

Binding of heparin by type III domains and peptides from the carboxy terminal hep-2 region of fibronectinK C Ingham, S A Brew, M M Migliorini, et al.

Vox Sanguinis|January 1, 1985

Biological and physical properties of fibronectin pasteurized in the presence of stabilizersS I Miekka, T F Busby, L Tarshis, et al.

Haemophilia : the Official Journal of the World Federation of Hemophilia|January 5, 1999

New methods for inactivation of lipid-enveloped and non-enveloped virusesS I Miekka, T F Busby, B Reid, et al.

The Journal of Biological Chemistry|August 4, 1995

Heparin binding by fibronectin module III-13 involves six discontinuous basic residues brought together to form a cationic cradleT F Busby, W S Argraves, S A Brew, et al.

Pageof 2